Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease.
Thomas H Oosterhof, Eleanor Mitchell, Alberto Ascherio...
https://pubmed.ncbi.nlm.nih.gov/42448717/Actively Recruiting
Led by Radboud University Medical Center · Updated on 2026-10-15
600
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are evaluating whether a smartphone app can help increase daily physical activity levels in people aged 50 and older who carry the LRRK2 G2019S or GBA1 N370S genetic mutations linked to a higher risk of developing Parkinsons disease. The study aims to test the feasibility of this remote exercise intervention over 24 months and explore its effect on early signs of Parkinsons disease progression using digital biomarkers. This trial is part of an international effort to understand how exercise might influence prodromal Parkinsons symptoms and disease progression. Participants will use the Slow-SPEED smartphone app to gradually increase their daily steps and minutes of moderate-to-vigorous physical activity based on their own baseline levels. The app provides feedback and motivation to support participants in reaching their personalized activity goals. The study randomly assigns participants to two groups with different targets for physical activity increase. The intervention lasts 24 months, with activity tracked using Fitbit smartwatches and digital assessments. During the study, participants will be monitored remotely through digital tools that measure physical activity, motor and non-motor symptoms, heart rate, sleep patterns, cognition, mood, and quality of life at multiple time points. Researchers will assess changes in a composite prodromal load score and physical fitness markers to help develop a better understanding of early Parkinsons disease. The study also measures feasibility outcomes such as retention rates and completeness of digital data collection. Total participation spans 24 months with ongoing assessments throughout this period.
CONDITIONS
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
T
Thomas Oosterhof, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Radboud University Medical Center
Lead Sponsor
Stichting ParkinsonNL
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Large physical activity increase via app | Small physical activity increase via app |
|---|---|---|
| What it is | A behavioural intervention using the Slow‑SPEED smartphone app to set a large increase in daily step count and moderate‑to‑vigorous physical activity relative to baseline | A behavioural intervention using the Slow‑SPEED smartphone app to set a small increase in daily step count and moderate‑to‑vigorous physical activity relative to baseline |
| Role in trial | Experimental arm assigned to a higher physical activity target delivered via the app | Active comparator arm assigned to a lower physical activity target delivered via the app |
| Primary use in trial | To test whether greater activity increase leads to better outcomes in slowing prodromal Parkinson’s progression | To serve as comparison with more modest activity increase for assessing relative effects |
| How it is delivered | Participants use their own smartphone with the Slow‑SPEED app for 2 years, receiving feedback and support toward a large relative increase in step count and MVPA | Participants use their own smartphone with the Slow‑SPEED app for 2 years, receiving feedback and support toward a small relative increase in step count and MVPA |
| Evidence status beyond trial | Evidence supports general benefit of structured exercise and increased physical activity in early Parkinson’s disease or prodromal stages | Benefits of modest physical activity increases are supported by broader evidence in Parkinson’s prevention or symptom management |
| Important risks | Risks may include falls, over‑exertion, or heart rate changes with increased activity | Similar risks of falls or over‑exertion exist even with modest activity increase |
| Important limitations | Effectiveness depends on app engagement and adherence over a long 2‑year period | Modest activity dose may limit observable effect size compared to higher activity |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 remote screening visit
Duration - 4 weeks
Participants wear a Fitbit smartwatch to measure their baseline physical activity levels for 4 weeks.
Continuous remote monitoring
Duration - 24 months
Participants use the Slow-SPEED smartphone app to increase their daily steps and minutes of moderate-to-vigorous physical activity based on their baseline. The app provides motivation and feedback remotely.
Ongoing remote assessments and data collection
Duration - Throughout the 24-month intervention
Regular digital assessments of motor and non-motor symptoms, physical fitness, sleep, mood, cognition, and quality of life are conducted remotely throughout the study.
Periodic remote evaluations at predefined intervals
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Thomas H Oosterhof, Eleanor Mitchell, Alberto Ascherio...
https://pubmed.ncbi.nlm.nih.gov/42448717/Radboud University Medical Center
Lead Sponsor
Stichting ParkinsonNL
Collaborating Sponsor